Assessing the impact of cardiovascular disease [whitepaper]

Cardiovascular disease (CVD) is a general term that refers to a group of disorders that affect the heart and blood vessels, including heart attacks, strokes, heart failure, arrhythmia, and heart valve complications. CVD is the leading cause of death in the United States, and for those who live with a diagnosis, managing medications can be a major burden. For this reason, clinical trials that aim to discover new potential treatments can be a vital part of improving the lives of those diagnosed.

Antidote has over 16,000 CVD patients in our database, and we analyzed their profiles to learn more about the impact of this disease and what researchers should know when recruiting for clinical trials. This whitepaper covers:

• Demographics of CVD patients
• The impact of racial disparities on CVD statistics
• The prevalence of various types of CVD
• What impacts clinical trials can make

Use the form to access it today and learn more.